Vivosim Lab Inc (VIVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Sales | 18 | 40 | 26 | 28 | 37 |
| Gross Profit | 18 | 40 | 26 | 28 | 37 |
| Operating Expenses | 2,777 | 3,227 | 2,776 | 2,663 | 2,952 |
| Operating Income | -2,759 | -3,187 | -2,750 | -2,635 | -2,915 |
| Interest Expense | 4 | 4 | 4 | 0 | 4 |
| Other Income | 1,428 | -2,573 | 63 | 92 | 76 |
| Pre-tax Income | -1,335 | -5,764 | -2,691 | -2,543 | -2,843 |
| Income Tax | 3 | N/A | N/A | 2 | N/A |
| Net Income Continuous | -1,338 | -5,764 | -2,691 | -2,545 | -2,843 |
| Net Income | $-1,338 | $-5,764 | $-2,691 | $-2,545 | $-2,843 |
| EPS Basic Total Ops | -0.25 | -2.20 | -1.03 | -0.98 | -1.14 |
| EPS Basic Continuous Ops | -0.26 | -2.20 | -1.03 | -0.98 | -1.14 |
| EPS Diluted Total Ops | -0.25 | -2.20 | -1.03 | -0.98 | -1.14 |
| EPS Diluted Continuous Ops | -0.26 | -2.20 | -1.03 | -0.98 | -1.14 |
| EPS Diluted Before Non-Recurring Items | N/A | -2.21 | -1.03 | -0.98 | -1.14 |
| EBITDA(a) | $-2,719 | $-3,144 | $-2,698 | $-2,576 | $-2,854 |